Monday, August 25th, 2025
Stock Profile: LFCR
LFCR Logo

Lifecore Biomedical, Inc. (LFCR)

Market: NASD | Currency: USD

Address: 3515 Lyman Boulevard

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The Show more




📈 Lifecore Biomedical, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for Lifecore Biomedical, Inc.


DateReported EPS
2025-10-03 (estimated upcoming)-
2025-08-07-0.06
2025-04-03-0.47
2025-01-02-0.25
2024-10-04-0.53
2024-08-26-0.2
2024-08-090.42
2024-08-090.39
2024-08-09-0.35
2023-08-31-1.19
2023-06-01-0.51
2023-03-16-0.42
2022-10-06-0.41
2022-08-10-1.24
2022-04-05-0.43
2022-01-05-1.3
2021-09-29-0.32
2021-07-28-0.1
2021-04-07-0.19
2021-01-06-0.45
2020-10-06-0.38
2020-08-11-0.52
2020-03-31-0.39
2020-01-02-0.23
2019-10-01-0.16




📰 Related News & Research


No related articles found for "lifecore biomedical".